Aurinia Pharmaceuticals Inc (AUPH)

[CoolG73]

BR, lower dose is more efficient and more durable , hence 100% of the patients maintained a CR between week 24 and 48 ( only 75% maintained a CR in High dose) but if you split the study time you can see that low dose is more efficient in the first 24 weeks (33% low dose vs 27% high dose at week 24) and high dose is more efficient in the second 24 weeks (20% high dose vs 16% low dose between week 24 and week 48). this proves that VCS is Dose Respondent, but when you consider the whole study , low dose is more efficient because it is more durable and has a quicker response. also the high dose had more AEs and you can see that in any of the company's presentations.